Complement activation impacts B-cell depletion by both type I and type II CD20 monoclonal antibodies

被引：4

作者：

Beurskens, Frank J. ^{[1
]}

Ruuls, Sigrid R. ^{[1
]}

Engelberts, Patrick J. ^{[1
]}

Vink, Tom ^{[1
]}

Mackus, Wendy J. ^{[1
]}

van de Winkel, Jan G. J. ^{[1
]}

Parren, Paul W. H. I. ^{[1
]}

机构：

[1] Genmab, NL-3584 CM Utrecht, Netherlands

来源：

BLOOD | 2008年 / 112卷 / 10期

关键词：

D O I：

10.1182/blood-2008-07-171082

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：4354 / 4355

页数：4

共 10 条

[1] Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation [J].

Beers, Stephen A. ;

Chan, Claude H. T. ;

James, Sonya ;

French, Ruth R. ;

Attfield, Kathrine E. ;

Brennan, Claire M. ;

Ahuja, Anupama ;

Shlomchik, Mark J. ;

Cragg, Mark S. ;

Glennie, Martin J. .

BLOOD, 2008, 112 (10) :4170-4177

[2] SENSITIVE HEMOLYTIC ASSAY OF MOUSE COMPLEMENT [J].

BERDEN, JHM ;

HAGEMANN, JFHM ;

KOENE, RAP .

JOURNAL OF IMMUNOLOGICAL METHODS, 1978, 23 (1-2) :149-159

[3]

Golay J, 2006, HAEMATOL-HEMATOL J, V91, P176

[4] Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy [J].

Gong, Q ;

Ou, QL ;

Ye, SM ;

Lee, WP ;

Cornelius, J ;

Diehl, L ;

Lin, WY ;

Hu, ZL ;

Lu, YM ;

Chen, YM ;

Wu, Y ;

Meng, YG ;

Gribling, P ;

Lin, ZH ;

Nguyen, K ;

Tran, T ;

Zhang, YF ;

Rosen, H ;

Martin, F ;

Chan, AC .

JOURNAL OF IMMUNOLOGY, 2005, 174 (02) :817-826

[5] Impaired IgG-dependent anaphylaxis and arthus reaction in Fc gamma RIII (CD16) deficient mice [J].

Hazenbos, WLW ;

Gessner, JE ;

Hofhuis, FMA ;

Kuipers, H ;

Meyer, D ;

Heijnen, IAFM ;

Schmidt, RE ;

Sandor, M ;

Capel, PJA ;

Daeron, M ;

vandeWinkel, JGJ ;

Verbeek, JS .

IMMUNITY, 1996, 5 (02) :181-188

[6] Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc [J].

Idusogie, EE ;

Presta, LG ;

Gazzano-Santoro, H ;

Totpal, K ;

Wong, PY ;

Ultsch, M ;

Meng, YG ;

Mulkerrin, MG .

JOURNAL OF IMMUNOLOGY, 2000, 164 (08) :4178-4184

[7] Rituximab infusion promotes rapid complement depletion and acute CD20 loss in chronic lymphocytic leukemia [J].

Kennedy, AD ;

Beum, PV ;

Solga, MD ;

DiLillo, DJ ;

Lindorfer, MA ;

Hess, CE ;

Densmore, JJ ;

Williams, ME ;

Taylor, RP .

JOURNAL OF IMMUNOLOGY, 2004, 172 (05) :3280-3288

[8] ASSAY OF CLASSICAL AND ALTERNATIVE PATHWAY ACTIVITIES OF MURINE COMPLEMENT USING ANTIBODY-SENSITIZED RABBIT ERYTHROCYTES [J].

TANAKA, S ;

SUZUKI, T ;

NISHIOKA, K .

JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 86 (02) :161-170

[9] Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas [J].

Teeling, JL ;

French, RR ;

Cragg, MS ;

van den Brakel, J ;

Pluyter, M ;

Huang, H ;

Chan, C ;

Parren, PWHI ;

Hack, CE ;

Dechant, M ;

Valerius, T ;

van de Winkel, JGJ ;

Glennie, MJ .

BLOOD, 2004, 104 (06) :1793-1800

[10] The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy [J].

Uchida, JJ ;

Hamaguchi, Y ;

Oliver, JA ;

Ravetch, JV ;

Poe, JC ;

Haas, KM ;

Tedder, TF .

JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (12) :1659-1669

← 1 →